Therefore, our study suggests that VIRMA can promote the proliferation, migration, and invasion of HNSCC through its involvement in m6A-mediated regulation of UBR5. VIRMA holds potential as a diagnostic and therapeutic biomarker. Here, UBR5 is linked to head and neck squamous cell carcinoma.